身体为什么会逐渐失去恢复力（中）：当清理与供能逐渐变慢——理解自噬、营养感知、线粒体与细胞衰老Why Does the Body Gradually Lose Its Capacity to Recover? (Part II): When Cellular Cleanup and Energy Supply Slow Down — Understanding Autophagy, Nutrient Sensing, Mitochondria, and Cellular Senescence

When we are younger, a hard workout, back-to-back business trips, or a recent cold can often be followed by just a few days of rest before we return to our usual rhythm. As we age, the same strain tends to leave a longer “tail”: soreness lingers, and even after enough sleep, we may still feel as though the battery has not fully recharged. When recovery slows, the body is often still dealing with invisible cleanup work behind the scenes.

For recovery to take place, cells need to detect damage, dismantle worn-out components, recycle raw materials, organize new synthesis, and deliver energy where it is needed. Cells with more severe damage may temporarily stop working, wait for repair, or exit in an orderly manner. If one step becomes backlogged, the steps that follow are slowed as well.

The previous article looked at the genome, telomeres, epigenetics, and proteostasis — how cells preserve and read information while maintaining proteins. This second part turns to four additional “hallmarks of aging”: disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, and cellular senescence. Together, they are deeply involved in the cell’s everyday maintenance system.[1][2]

Cleanup, resource allocation, energy supply, and the management of cells that need to stop working can each leave a mark when they become impaired. Diet, sleep, physical activity, psychological stress, disease history, and environmental exposures also help determine how much reserve remains in this maintenance system.[3]

1. Disabled Macroautophagy: Can Worn-Out Components Be Dismantled and Recycled in Time?

Many structures inside a cell must be continually renewed. Macroautophagy is one of the best-studied forms of autophagy. The cell first encloses damaged proteins, aging organelles, and other materials within a double-membrane structure to form an autophagosome. The autophagosome then fuses with a lysosome, where its contents are broken down. Some of the resulting materials return to pathways involved in synthesis and energy production.[4]

Alternating periods of eating and fasting, exercise, and short-term stress can all alter autophagic activity. Cells use autophagy to process aggregated proteins and damaged mitochondria, while the recycled materials can support subsequent rebuilding. In this way, autophagy links protein quality control with mitochondrial renewal.

With advancing age, the formation, transport, fusion, and degradation of autophagosomes may all be affected.[2][4] When the rate of breakdown can no longer keep pace with damage, abnormal proteins and impaired mitochondria remain in the cell for longer. As energy supply declines, cleanup and rebuilding receive less support, making accumulated damage harder to clear.

Autophagy is often discussed together with fasting, yet autophagic activity in different tissues cannot be reliably inferred from a fixed fasting duration. Age, nutritional status, disease, and medications can all change the response. Prolonged fasting may also increase the risk of hypoglycemia, muscle loss, or inadequate nutrition. Older adults, people with low body weight, those recovering from illness, and people taking glucose-lowering medications should be especially cautious.

Cleanup itself consumes resources and also depends on appropriate timing. How a cell allocates resources among growth, storage, and repair is largely coordinated by nutrient-sensing systems.

2. Deregulated Nutrient Sensing: How Do Growth and Repair Take Turns Receiving Resources?

Cells monitor glucose, amino acids, and overall energy status, then adjust priorities through insulin-related signaling, mTOR, AMPK, and other pathways.[2][5] mTOR tends to favor growth and biosynthesis, whereas AMPK more strongly signals energy conservation and repair when energy is scarce. What matters is whether these signaling systems can switch at the right time.

After a meal, anabolic signals help tissues use incoming nutrients. During exercise, overnight fasting, or periods of increased energy demand, mobilization and repair pathways become more active. Chronically taking in more energy than is expended, allowing eating to crowd out sleep, or remaining physically inactive can make these transitions less responsive. Persistent dieting or inadequate protein intake can also leave tissue renewal short of the raw materials it needs.

Research on nutrient sensing is fundamentally concerned with “matching”: whether intake matches expenditure, whether protein intake is sufficient for age and activity level, and whether eating, sleep, and post-exercise rebuilding follow a workable rhythm. Calorie restriction has provided important mechanistic clues, while real-life application must also account for nutritional adequacy, sustainability, and individual safety.[5]

Even when resources are allocated appropriately, they still need to be converted into energy that cells can use directly. Mitochondria sit at the intersection of cellular cleanup, energy production, and stress signaling.

3. Mitochondrial Dysfunction: The Energy System Is Also Reading the Body’s State

The best-known role of mitochondria is to convert energy from nutrients into ATP. Every muscle contraction, the maintenance of electrical signals in neurons, and the synthesis of new proteins after damage all require ATP. Mitochondria also help regulate calcium ions. Calcium participates in muscle contraction, secretion, and cell communication, while excessive concentrations can increase cellular stress. Mitochondria can temporarily take up and release part of this calcium load to help maintain balance.[6]

Mitochondria also participate in immune signaling and in the orderly elimination of cells. Signals released from damaged mitochondria, including mitochondrial DNA, can activate immune responses. When damage becomes too severe to repair, mitochondria help initiate programmed cell death so that the cell can exit in an orderly way. Mitochondrial shape also changes with cellular state: fusion can help share usable materials, while fission can isolate more severely damaged sections so they can later be removed through mitophagy.[6]

Mitochondrial activity naturally generates small amounts of reactive oxygen species. At moderate levels, these molecules participate in signaling involved in exercise adaptation. When they remain excessive over time, they increase the burden on DNA, lipids, and proteins. Through mitochondrial fusion and fission, antioxidant systems, and mitophagy, cells isolate and recycle the more severely damaged portions.

As we age, mitochondrial DNA, energy conversion, and quality-control systems may all change.[2][6] When cleanup falls behind, damaged mitochondria release more stress signals. As energy production declines, autophagy, protein renewal, and tissue rebuilding also lose energy support, allowing these forms of stress to reinforce one another.

Fatigue, reduced endurance, or slower recovery after exercise cannot by themselves be used to judge mitochondrial function. Anemia, thyroid disorders, infections, sleep disturbances, and many chronic diseases can produce similar experiences. When changes are persistent, pronounced, or disruptive to daily life, timely professional medical evaluation is appropriate.

When DNA damage, telomere attrition, and mitochondrial stress persist, some cells stop dividing as a way of containing risk. This brings us to the fourth hallmark: cellular senescence.

4. Cellular Senescence: Once a Cell Stops Working, Can It Leave on Time?

Cellular senescence describes a state in which a cell remains alive and metabolically active but no longer divides over the long term. Severe DNA damage, critically short telomeres, and abnormal growth signals can all trigger this state.[7] Senescence can limit the continued replication of damaged cells and also contributes to wound healing and tissue remodeling. Once the task is complete, the immune system normally helps remove these cells.

Problems become more likely when a temporary “shutdown” turns into prolonged retention. Senescent cells can release cytokines, proteases, and growth factors, creating what is known as the senescence-associated secretory phenotype (SASP). When these signals persist, surrounding cells, the extracellular matrix, and immune responses can all be affected, making the local environment more likely to remain in a state of low-grade alert.[7] It is like a factory that has stopped production but continues to release smoke and repeatedly sound an alarm: the factory itself is no longer producing, and its neighboring facilities also struggle to return to normal order.

In 2018, researchers transplanted a small number of senescent cells into mice and subsequently observed declines in walking speed, grip strength, and endurance. After some senescent cells were cleared using dasatinib and quercetin, physical function improved in aged mice and remaining lifespan after treatment increased.[8] These animal experiments strengthened the causal evidence linking senescent cells with functional decline, while the intervention cannot be directly transferred to humans.

In 2019, an open-label trial enrolled 14 patients with stable idiopathic pulmonary fibrosis who intermittently received dasatinib and quercetin for three consecutive days each week over three weeks. Measures of physical function, including walking speed and chair-rise performance, improved, while lung function showed no clear change.[9] The study was small and had no placebo control, so it was mainly useful for evaluating feasibility. The regimen also included a prescription drug and should not be imitated without medical supervision.

Young plasma is also frequently discussed in the context of “anti-aging.” In a 2005 heterochronic parabiosis experiment, the circulatory systems of young and old mice were connected, and changes were observed in muscle and liver regeneration in the older animals. This is a fundamentally different intervention from infusing young plasma into humans.[10] In 2023, technology entrepreneur Bryan Johnson tried plasma from younger donors, including blood donated by his 17-year-old son, and later said that testing showed no additional benefit, after which he stopped the intervention. The U.S. FDA has also warned that young-donor plasma has no approved anti-aging use and carries risks including allergic reactions, infection, and circulatory overload.[11]

Cellular senescence plays different roles across tissues and stages of life. Any intervention must therefore consider timing, selectivity, and safety. The goal is for damaged cells to stop when necessary and to leave once their role has been completed.

These four hallmarks can therefore be connected into one maintenance pathway: nutrient sensing allocates resources, autophagy dismantles worn-out components, mitochondria supply energy, and cellular senescence manages cells that have sustained severe damage. When backlogs develop at several points at once, overall recovery takes longer.

5. Which Practical Links Can Nutrition and Dietary Supplements Support?

Maintaining cellular cleanup and energy supply begins with repeatable daily rhythms. Regular sleep, aerobic and resistance exercise, and adequate total energy, protein, dietary fiber, and micronutrients create the conditions needed for metabolic regulation, mitochondrial renewal, and muscle rebuilding. Sudden increases in training load, chronic sleep deprivation, or aggressive dieting can temporarily push demand beyond the body’s processing capacity.

Dietary supplements can provide research with clearly defined ingredients and relatively consistent doses. When reading the evidence, it is important to consider the study population, ingredient specifications, dose, duration, primary endpoints, and safety. Labels such as “effective” or “ineffective” are often too simple to capture the full picture. Whether an ingredient has entered human research, whether it produces a measurable biological response, whether functional outcomes move in the same direction, and what questions the next study still needs to answer all shape its potential application value.

Urolithin A is produced when gut microbes metabolize ellagitannins and has attracted attention in research on mitophagy. In the repeated-dose phase of the first human study published in 2019, 36 healthy, sedentary older adults were assigned to placebo or 250, 500, or 1,000 mg/day of urolithin A for four weeks. Several plasma acylcarnitines decreased in the 500- and 1,000-mg groups, while expression of genes related to mitochondrial biogenesis and fatty-acid oxidation increased in skeletal muscle in the 1,000-mg group.[12] Acylcarnitines are metabolic intermediates in fatty-acid energy metabolism. These changes showed that mitochondrial metabolic pathways produced a measurable response to the intervention, representing an important step from mechanistic clues toward human observation. The four-week study did not establish walking ability, muscular endurance, or perceived fatigue as its primary functional conclusions. Its value lay in confirming that relevant metabolic pathways could be observed in human research and in providing dose and biomarker guidance for subsequent studies.

A later study enrolled 88 adults aged 40–64 who were overweight and sedentary. Participants received 500 or 1,000 mg of urolithin A daily for four months. At the end of the trial, there was no significant between-group difference in the primary endpoint of peak thigh-muscle power. At the same time, compared with baseline, hamstring strength increased by about 12% and 9.8% in the two groups, respectively; VO₂max increased by about 10.7% in the 1,000-mg group; and six-minute walking distance increased by about 33 meters.[13] Hamstring strength contributes to standing up and gait stability, VO₂max reflects the body’s capacity to use oxygen, and the six-minute walk is closer to sustained activity in daily life. The primary endpoint has not yet shown a consistent advantage, while several functional measures at different levels moved in the same direction. These findings provide application clues worth further testing for the maintenance of muscle strength and endurance in sedentary middle-aged adults. Future studies still need to determine the most suitable populations, doses, and outcome measures.

Another study enrolled 66 adults aged 65–90 who received 1,000 mg of urolithin A daily for four months. After two months, participants in the urolithin A group completed more repeated contractions of the hand and lower-leg muscles before fatigue than those receiving placebo. At four months, plasma acylcarnitines, ceramides, C-reactive protein, and other biomarkers had decreased.[14] Changes in local muscular endurance and mitochondrial metabolic markers moved in the same direction, beginning to connect cellular mechanisms with functions that people can experience physically. Six-minute walking distance increased by an average of about 61 meters in the urolithin A group and about 43 meters in the placebo group, although the between-group difference did not reach statistical significance. Walking performance is also influenced by cardiopulmonary fitness, joints, activity habits, and baseline physical capacity. The existing results provide support for further investigation of urolithin A in age-related maintenance of muscular endurance, with larger samples, longer study periods, and more targeted populations needed for confirmation.

Spermidine is a polyamine that occurs naturally in the human body and in food, with relatively high levels found in grains, legumes and soy foods, mushrooms, and other plant foods.[15] It is associated with autophagy, mitochondrial quality control, and neuronal homeostasis. A randomized pilot trial published in 2018 enrolled 30 adults aged 60–80 with subjective memory decline. Participants received a plant extract providing 1.2 mg of spermidine per day for three months. Compared with placebo, the spermidine group showed a moderate signal of improvement on a memory-discrimination task, and overall tolerability was good.[16] This type of task examines the ability to distinguish between similar images or experiences and is related to hippocampal memory processing. Although the sample was small, the study provided early human evidence that spermidine could be studied in relation to cognition and produce a functional signal.

Another brain-imaging study examined habitual diet and did not assign participants to a spermidine supplement. Researchers used a questionnaire covering 89 food categories to assess the diets of 90 people with subjective cognitive decline and 47 healthy older adults over the previous year, then estimated spermidine intake based on the polyamine content of those foods.[17] Participants with relatively higher dietary spermidine intake had relatively larger hippocampal volumes and greater cortical thickness in some brain regions. Here, “higher intake” referred to relative differences among participants; the paper did not define a specific milligram-per-day threshold for high intake. Because diet and brain structure were measured at the same point in time, the findings show an association and cannot establish that dietary spermidine directly caused changes in brain structure. The study provided a direction for future research and highlighted the need for trials using clearly specified ingredients, doses, and intervention periods.

The subsequent SmartAge trial enrolled 100 adults aged 60–90 who reported subjective memory decline but had no established cognitive impairment. Participants received a wheat-germ extract providing 0.9 mg of spermidine per day for 12 months. The primary memory endpoint showed no significant between-group difference, and overall safety was acceptable. Exploratory analyses, however, identified possible signals of benefit in verbal memory and inflammatory markers.[18] The researchers noted that the intervention increased total daily spermidine supply by only about 10%, suggesting that future studies should test higher doses. These findings indicate that, with a 0.9 mg dose, this ingredient form, this population, and these endpoints, a consistent advantage has yet to emerge. Taken together with the earlier randomized trial and the observational brain-structure study, spermidine remains a candidate ingredient with application potential. Future work needs to clarify ingredient specifications, actual absorption and exposure, appropriate dose, target populations, and functional endpoints so that early signals can be translated into more consistent human outcomes.

All doses described above come from specific studies and should not be treated as direct recommendations for use. People who are pregnant or breastfeeding, have chronic diseases or abnormal liver or kidney function, or are taking medications should first seek professional assessment. Supplements can provide nutritional support, while regular eating, exercise, sleep, and necessary medical care remain the foundation of recovery.

Between cellular mechanisms and changes that people can actually feel lie the ingredient, formulation, dose, duration, and validation in the intended population. SUPER-SYN focuses on how research can move step by step toward everyday function: which biological responses have already been confirmed, whether strength, endurance, or cognition show changes in the same direction, and how formulation and dose can turn early signals into more consistent outcomes. Mechanisms provide direction, while human studies help identify application pathways that are more likely to deliver meaningful value.

Conclusion: Recovery Depends on Coordination Between Cleanup, Energy Supply, and Cellular Exit

Autophagy dismantles and recycles cellular components, nutrient sensing coordinates growth and repair, mitochondria provide energy and state signals, and cellular senescence applies a shutdown mechanism when damage becomes too severe. Recovery depends on how well these processes work together.

When cleanup cannot keep pace with damage, resource switching becomes slower, energy pressure rises, and cells that have stopped dividing remain in place for too long, the body takes more time to return to its previous state. Stable rhythms of sleep, activity, and eating can create continuous windows for cleanup and rebuilding.

Once cellular repair is complete, tissues still require coordination on a larger scale. The next article will turn to stem cells, intercellular communication, chronic inflammation, and dysbiosis, exploring how local cellular stress can expand into a whole-body coordination problem.

References

1. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The Hallmarks of Aging. Cell. 2013;153(6):1194-1217. doi:10.1016/j.cell.2013.05.039.
2. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of Aging: An Expanding Universe. Cell. 2023;186(2):243-278. doi:10.1016/j.cell.2022.11.001.
3. Bland JS. The Disease Delusion: Conquering the Causes of Chronic Illness for a Healthier, Longer, and Happier Life. HarperWave, 2014.
4. Mizushima N, Levine B. Autophagy in Human Diseases. New England Journal of Medicine. 2020;383(16):1564-1576. doi:10.1056/NEJMra2022774.
5. Green CL, Lamming DW, Fontana L. Molecular mechanisms of dietary restriction promoting health and longevity. Nature Reviews Molecular Cell Biology. 2022;23(1):56-73. doi:10.1038/s41580-021-00411-4.
6. Sun N, Youle RJ, Finkel T. The Mitochondrial Basis of Aging. Molecular Cell. 2016;61(5):654-666. doi:10.1016/j.molcel.2016.01.028.
7. Gorgoulis V, Adams PD, Alimonti A, et al. Cellular Senescence: Defining a Path Forward. Cell. 2019;179(4):813-827. doi:10.1016/j.cell.2019.10.005.
8. Xu M, Pirtskhalava T, Farr JN, et al. Senolytics improve physical function and increase lifespan in old age. Nature Medicine. 2018;24(8):1246-1256. doi:10.1038/s41591-018-0092-9.
9. Justice JN, Nambiar AM, Tchkonia T, et al. Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine. 2019;40:554-563. doi:10.1016/j.ebiom.2018.12.052.
10. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433(7027):760-764. doi:10.1038/nature03260.
11. U.S. Food and Drug Administration. Important Information About Young Donor Plasma Infusions Offered for Profit. Safety Communication. 2019.
12. Andreux PA, Blanco-Bose W, Ryu D, et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature Metabolism. 2019;1(6):595-603. doi:10.1038/s42255-019-0073-4.
13. Singh A, D’Amico D, Andreux PA, et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Reports Medicine. 2022;3(5):100633. doi:10.1016/j.xcrm.2022.100633.
14. Liu S, D’Amico D, Shankland E, et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Network Open. 2022;5(1):e2144279. doi:10.1001/jamanetworkopen.2021.44279.
15. Muñoz-Esparza NC, Latorre-Moratalla ML, Comas-Basté O, et al. Polyamines in Food. Frontiers in Nutrition. 2019;6:108. doi:10.3389/fnut.2019.00108.
16. Wirth M, Benson G, Schwarz C, et al. The effect of spermidine on memory performance in older adults at risk for dementia: A randomized controlled trial. Cortex. 2018;109:181-188. doi:10.1016/j.cortex.2018.09.014.
17. Schwarz C, Horn N, Benson G, et al. Spermidine intake is associated with cortical thickness and hippocampal volume in older adults. NeuroImage. 2020;221:117132. doi:10.1016/j.neuroimage.2020.117132.
18. Schwarz C, Benson GS, Horn N, et al. Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial. JAMA Network Open. 2022;5(5):e2213875. doi:10.1001/jamanetworkopen.2022.13875.